B

Bioton SA
WSE:BIO

Watchlist Manager
Bioton SA
WSE:BIO
Watchlist
Price: 3.155 PLN -0.47% Market Closed
Market Cap: 270.9m PLN
Have any thoughts about
Bioton SA?
Write Note

Relative Value

The Relative Value of one BIO stock under the Base Case scenario is 4.008 PLN. Compared to the current market price of 3.155 PLN, Bioton SA is Undervalued by 21%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIO Relative Value
Base Case
4.008 PLN
Undervaluation 21%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
65
vs Industry
83
Median 3Y
1.6
Median 5Y
1.6
Industry
8.1
vs History
vs Industry
1
Median 3Y
72.4
Median 5Y
18.3
Industry
23
vs History
63
vs Industry
13
Median 3Y
6.6
Median 5Y
6.6
Industry
23.4
vs History
vs Industry
1
Median 3Y
-17.5
Median 5Y
-17.5
Industry
27.3
vs History
93
vs Industry
71
Median 3Y
0.5
Median 5Y
0.6
Industry
2.6
vs History
73
vs Industry
72
Median 3Y
1.7
Median 5Y
1.7
Industry
8.1
vs History
33
vs Industry
56
Median 3Y
4.4
Median 5Y
4.3
Industry
9.6
vs History
17
vs Industry
11
Median 3Y
6.9
Median 5Y
6.8
Industry
4.3
vs History
7
vs Industry
2
Median 3Y
22.8
Median 5Y
15.6
Industry
3.8
vs History
71
vs Industry
13
Median 3Y
6.8
Median 5Y
6.9
Industry
6
vs History
33
vs Industry
1
Median 3Y
11.6
Median 5Y
12.6
Industry
3.8
vs History
95
vs Industry
67
Median 3Y
0.4
Median 5Y
0.4
Industry
4.8

Multiples Across Competitors

BIO Competitors Multiples
Bioton SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
PL
Bioton SA
WSE:BIO
270.9m PLN 1.5 -39.6 8 145.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 678 545.3 -179 080.5 -217 460.8 -214 979.3
US
Abbvie Inc
NYSE:ABBV
299.8B USD 5.4 59 14.8 22.7
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.6 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.7B USD 11.7 -259.9 26.3 27.6
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 4.1 910.9 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 869.7 -477.1 -519.6 -505.7
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.5 20.7 25.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
86.2B USD 6.2 18.5 17 18.9
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.2 -59.4 -53.6
NL
argenx SE
XBRU:ARGX
34B EUR 18.4 -129.2 -103.9 -75.7
P/E Multiple
Earnings Growth
PL
B
Bioton SA
WSE:BIO
Average P/E: 211.9
Negative Multiple: -39.6
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 080.5 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.6
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -259.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -477.1 N/A
AU
CSL Ltd
ASX:CSL
33.5
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.2 N/A
EV/EBITDA Multiple
EBITDA Growth
PL
B
Bioton SA
WSE:BIO
Average EV/EBITDA: 16.3
8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 460.8 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.3
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -519.6 N/A
AU
CSL Ltd
ASX:CSL
20.7
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -103.9 N/A
EV/EBIT Multiple
EBIT Growth
PL
B
Bioton SA
WSE:BIO
Average EV/EBIT: 40.6
145.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 979.3 N/A
US
Abbvie Inc
NYSE:ABBV
22.7
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.6
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
AU
CSL Ltd
ASX:CSL
25.8
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -75.7 N/A

See Also

Discover More
Back to Top